Obstet Gynecol:骨盆重建手术后需要限制活动吗?

2017-04-03 xing.T MedSci原创

脱垂手术后3个月,自由活动组女性与建议限制术后活动的妇女相比满意度同样高。术后自由活动的妇女脱垂和尿道症状较少,并且具有相似的短期解剖结局,表明允许妇女术后恢复正常活动可能改善盆底结局。


近日,妇产科权威杂志Obstetrics and Gynecology上发表了一研究文章,研究人员旨在评估脱垂重建手术后患者接受术后运动建议(自由性与限制性)与患者满意度和盆底症状之间的相关性。

在这项多中心、随机、双盲的临床试验中,接受脱垂重建手术的妇女术后随机分为自由活动组与建议限制性术后活动组。自由活动建议指导妇女术后活动按照自身的节奏进行,对于提升或高强度运动没有限制。相反,限制性建议指导妇女避免3个月内进行重力提升或剧烈运动。该研究的主要结局是患者满意度,是通过术后3个月采用5分Likert量表的问题“您对脱垂手术的结果如何满意?”进行评估。次要结局包括解剖结局和盆底症状。

从2014年9月至2015年12月,共筛选了130名妇女,其中108人被随机分配。最终,95人被分为两组进行干预。(n=45自由活动,n=50限制活动),并完成主要结局评估。基线特征(包括盆腔器官脱垂程度和人口统计学特征)和手术干预情况在两组间无差异。大多数妇女接受了侵入性阴道骶骨缝合术(58例),其次为阴道悬吊术(27例)或阴道封闭术(9例)。自由活动组和限制性活动组的满意度一样高(98% vs. 94%,比值比为0.36 [0.036-3.55],P=0.619)。 解剖结局在组间没有差异; 然而,自由活动组中报告的盆底症状较少。

脱垂手术后3个月,自由活动组女性与建议限制术后活动的妇女相比满意度同样高。术后自由活动的妇女脱垂和尿道症状较少,并且具有相似的短期解剖结局,表明允许妇女术后恢复正常活动可能改善盆底结局。

原始出处:

Mueller, Margaret G, et al. Activity Restriction Recommendations and Outcomes After Reconstructive Pelvic Surgery: A Randomized Controlled Trial.Obstetrics & Gynecology.2017.http://journals.lww.com/greenjournal/Fulltext/2017/04000/Activity_Restriction_Recommendations_and_Outcomes.3.aspx

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011284, encodeId=f143201128415, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Mon Mar 12 16:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043948, encodeId=198520439481c, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Sep 12 21:39:00 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184970, encodeId=86fb1849e03b, content=学习过了,分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Apr 04 00:19:58 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184952, encodeId=2cf3184952aa, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Apr 04 00:05:12 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184925, encodeId=06cb18492512, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/07/1c4abd500121276ffd9d68fbf898ae22.jpg, createdBy=4f602041120, createdName=szc1181881761, createdTime=Mon Apr 03 21:50:48 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2018-03-12 yhy100200
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011284, encodeId=f143201128415, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Mon Mar 12 16:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043948, encodeId=198520439481c, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Sep 12 21:39:00 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184970, encodeId=86fb1849e03b, content=学习过了,分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Apr 04 00:19:58 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184952, encodeId=2cf3184952aa, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Apr 04 00:05:12 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184925, encodeId=06cb18492512, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/07/1c4abd500121276ffd9d68fbf898ae22.jpg, createdBy=4f602041120, createdName=szc1181881761, createdTime=Mon Apr 03 21:50:48 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011284, encodeId=f143201128415, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Mon Mar 12 16:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043948, encodeId=198520439481c, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Sep 12 21:39:00 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184970, encodeId=86fb1849e03b, content=学习过了,分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Apr 04 00:19:58 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184952, encodeId=2cf3184952aa, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Apr 04 00:05:12 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184925, encodeId=06cb18492512, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/07/1c4abd500121276ffd9d68fbf898ae22.jpg, createdBy=4f602041120, createdName=szc1181881761, createdTime=Mon Apr 03 21:50:48 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-04-04 明天会更好!

    学习过了,分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2011284, encodeId=f143201128415, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Mon Mar 12 16:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043948, encodeId=198520439481c, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Sep 12 21:39:00 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184970, encodeId=86fb1849e03b, content=学习过了,分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Apr 04 00:19:58 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184952, encodeId=2cf3184952aa, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Apr 04 00:05:12 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184925, encodeId=06cb18492512, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/07/1c4abd500121276ffd9d68fbf898ae22.jpg, createdBy=4f602041120, createdName=szc1181881761, createdTime=Mon Apr 03 21:50:48 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-04-04 飛歌

    学习了很有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2011284, encodeId=f143201128415, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Mon Mar 12 16:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043948, encodeId=198520439481c, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Sep 12 21:39:00 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184970, encodeId=86fb1849e03b, content=学习过了,分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Apr 04 00:19:58 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184952, encodeId=2cf3184952aa, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Tue Apr 04 00:05:12 CST 2017, time=2017-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184925, encodeId=06cb18492512, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/07/1c4abd500121276ffd9d68fbf898ae22.jpg, createdBy=4f602041120, createdName=szc1181881761, createdTime=Mon Apr 03 21:50:48 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-04-03 szc1181881761

    学习了

    0

相关资讯

PNAS:人类女性骨盆发育,围绕生育而来?

科研人员报告了证据表明,人类女性骨盆在女性的一生时间里适应了变化的产科需求。产科困境假说认为,人类女性骨盆的尺寸与形状代表了对生下大脑尺寸大的后代的宽骨盆需求与用于有效地两足运动的窄骨盆的需求的折中。这个假说近来在多个方面已经受到了挑战。 Marcia S. Ponce de León及其同事提出了一个修改过的产科困境假说,它认为在女性的一生中,骨盆结构发生变

JOT:骨盆骨折外固定带置于大转子水平效果佳

  对于不稳定骨盆骨折而言,骨盆外固定带固定一种较长常用的急救处理方式,这种固定方式有利于患者搬运过程中的出血控制。骨盆外固定带使用时通常放置于两侧髂前上棘水平,但这种固定方式不利于临床医生实施腹部查体,患者的舒适度也较差。   为了解决这一问题,最近,美国纽约罗切斯特大学骨科医生Mark L. Prasarn, MD等提出在股骨大转子水平放置骨盆外固定带装置,他们通过尸体模型考察这种固

骨科医生从未见过的动态扫描图像:骨骼

图一:足部骨骼 图二:肋骨与心脏定位 图三:肋骨、骨盆和股骨三维图像 图四:螺钉立体图像清晰可见 图五:腰椎、骨盆与血管定位图  

Injury:骨盆创伤并发症死亡高危因素

骨盆创伤的病死率在所有骨骼肌肉创伤中位居首位,根据损伤类型,其死亡率在2%—40%之间。即使在初次创伤中幸存下来的患者,心脏事件、感染及静脉血栓栓塞是最常见且很严重的并发症。这些并发症可能会进一步影响治疗效果,增加死亡的累积风险,降低生活质量。但是过去的研究中未能详尽的阐明导致这些并发症及死亡的重要危险因素。 针对这一情况,美国德州理工大学医学院的William Arroyo教授进行了一项研